Catalyst Wire Dossier Catalyst Wire Dossier

Mexiletine PR

Mexiletine · Lupin Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Mexiletine PR, covering 2026-01-26 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 [Phase 3]

See pricing